Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for NLST

Publication Year
Title PubMed Authors Journal Year Studies
Estimating Case-Fatality Reduction from Randomized Screening Trials Sudipta Saha, Zhihui (Amy) Liu and Olli Saarela EM 2018 NLST
Lung Cancer Screening in a Safety-Net Hospital: Implications of Screening a Real-World Population versus the National Lung Screening Trial. 30199643 Iaccarino JM, Steiling KA, Wiener RS Ann Am Thorac Soc 2018 NLST
Automatic segmentation of thoracic aorta segments in low-dose chest CT Julia M. H. Noothout, Bob D. de Vos, Jelmer M. Wolterink, Ivana Išgum Medical Imaging 2018 2018 NLST
Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia. 29689434 Wade S, Weber M, Caruana M, Kang YJ, Marshall H, Manser R, Vinod S, Rankin N, Fong K, Canfell K J Thorac Oncol 2018 NLST
Lung cancer risk in welders and foundry workers with a history of heavy smoking in the USA: The National Lung Screening Trial Jason Y Y Wong, Bryan A Bassig, Wei Jie Seow, Wei Hu, Bu-Tian Ji, Aaron Blair, Debra T Silverman, Qing Lan Occup Environ Med 2017 NLST
Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants. 28050695 Gierada DS, Pinsky PF, Duan F, Garg K, Hart EM, Kazerooni EA, Nath H, Watts JR, Aberle DR Eur Radiol 2017 NLST
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. 28376113 Ten Haaf K, Jeon J, Tammemägi MC, Han SS, Kong CY, Plevritis SK, Feuer EJ, de Koning HJ, Steyerberg EW, Meza R PLoS Med. 2017 NLST, PLCO
Malignancy estimation of Lung-RADS criteria for subsolid nodules on CT: accuracy of low and high risk spectrum when using NLST nodules. 28439653 Chung K, Jacobs C, Scholten ET, Mets OM, Dekker I, Prokop M, van Ginneken B, Schaefer-Prokop CM Eur Radiol 2017 NLST
Lung-RADS Category 4X: Does It Improve Prediction of Malignancy in Subsolid Nodules? 28339311 Chung K, Jacobs C, Scholten ET, Goo JM, Prosch H, Sverzellati N, Ciompi F, Mets OM, Gerke PK, Prokop M, van Ginneken B, Schaefer-Prokop CM Radiology 2017 NLST
Computed tomographic findings in subjects who died from respiratory disease in the National Lung Screening Trial. 28424361 Pompe E, de Jong PA, Lynch DA, Lessmann N, Išgum I, van Ginneken B, Lammers JJ, Mohamed Hoesein FAA Eur. Respir. J. 2017 NLST
WSISA: Making Survival Prediction from Whole Slide Histopathological Images Xinliang Zhu , Univerisity of Texas at Arlington, Tencent AI Lab , Jiawen Yao , Univerisity of Texas at Arlington, Tencent AI Lab , Feiyun Zhu , Univerisity of Texas at Arlington, Tencent AI Lab , Junzhou Huang , Univerisity of Texas at Arlington, T… IEEE 2017 NLST
Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial. 28245151 Yip R, Henschke CI, Xu DM, Li K, Jirapatnakul A, Yankelevitz DF AJR Am J Roentgenol 2017 NLST
Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada. 28170394 Ten Haaf K, Tammemägi MC, Bondy SJ, van der Aalst CM, Gu S, McGregor SE, Nicholas G, de Koning HJ, Paszat LF PLoS Med 2017 NLST
ConvNet-Based Localization of Anatomical Structures in 3-D Medical Images. 28252392 de Vos BD, Wolterink JM, de Jong PA, Leiner T, Viergever MA, Isgum I IEEE Trans Med Imaging 2017 NLST
Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. 27009070 Patz EF, Greco E, Gatsonis C, Pinsky P, Kramer BS, Aberle DR Lancet Oncol. 2016 NLST
Did death certificates and a death review process agree on lung cancer cause of death in the National Lung Screening Trial? 27006427 Marcus PM, Doria-Rose VP, Gareen IF, Brewer B, Clingan K, Keating K, Rosenbaum J, Rozjabek HM, Rathmell J, Sicks J, Miller AB Clin Trials 2016 NLST
CANARY Risk Management of Adenocarcinoma: The Future of Imaging? Finbar Foley , Srinivasan Rajagopalan , Sushravya M. Raghunath , Jennifer M. Boland , Ronald A. Karwoski , Fabien Maldonado , Brian J. Bartholmai , Tobias Peikert , j.semtcsv 2016 NLST
Normative reference values of thoracic aortic diameter in American College of Radiology Imaging Network (ACRIN 6654) arm of National Lung Screening Trial. 27203287 McComb BL, Munden RF, Duan F, Jain AA, Tuite C, Chiles C Clin Imaging 2016 NLST
Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening. 27179989 Katki HA, Kovalchik SA, Berg CD, Cheung LC, Chaturvedi AK JAMA 2016 NLST
The Potential Clinical, Resource Use, And Fiscal Impacts of Lung-Rads To Inform Lung Cancer Screening In Medicare J. Roth, S.D. Sullivan, S. Ramsey, B. Goulart Val Health 2016 NLST